Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity

The quadrivalent HPV vaccine (4vHPV) was originally recommended as a three-dose series (0/2/6 months), though delays in completing the series frequently occur. We previously found delayed dosing in girls resulted in similar or higher antibody titers compared to on-time dosing. Archived sera from 262...

Descripción completa

Detalles Bibliográficos
Autores principales: Brady, Allison M., Walter, Emmanuel B., Markowitz, Lauri E., Unger, Elizabeth R., Panicker, Gitika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482794/
https://www.ncbi.nlm.nih.gov/pubmed/31967933
http://dx.doi.org/10.1080/21645515.2019.1706410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482794/
https://www.ncbi.nlm.nih.gov/pubmed/31967933
http://dx.doi.org/10.1080/21645515.2019.1706410

Ejemplares similares